Investor day highlights include: a memorandum of understanding with Memorial Sloan Kettering Cancer Center and a novel new partnership with Boundless Bio, a next-generation precision oncology company
SOPHiA GENETICS' next-generation solution CarePath, fueled by current real world observational data, was previewed for attendees
https://finance.yahoo.com/news/sophia-genetics-unveils-strategy-drive-123800537.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.